OCFall23_01

Evolving Treatment Paradigms in HER2-Expressing Metastatic Breast Cancer: Integrating the Latest Evidence in Rural and Underserved Communities

Date

December 2, 2023

Explore related products in the following collection:

Oncology Congress - Dec

Speakers

Chris Prakash, MD

Medical Director, Texas Oncology - Paris

Harold J. Burstein, MD, PhD

Medical Oncologist, Dana-Farber Cancer Institute

Related Products

Thumbnail for 2024 ASCO Updates in Breast Cancer: Advancing Equitable Cancer Care in the Community

2024 ASCO Updates in Breast Cancer: Advancing Equitable Cancer Care in the Community

Thumbnail for Targeting the PI3K/AKT/PTEN Pathway for Treatment of Breast Cancer: Innovative Solutions for Equitable Care

Targeting the PI3K/AKT/PTEN Pathway for Treatment of Breast Cancer: Innovative Solutions for Equitable Care

Thumbnail for Evolving Treatment Paradigms in HR+/HER2- Early Breast Cancer: Advancing Equitable Care in Rural and Underserved Communities

Evolving Treatment Paradigms in HR+/HER2- Early Breast Cancer: Advancing Equitable Care in Rural and Underserved Communities

Thumbnail for Evolving Treatment Paradigms in Hepatocellular Carcinoma: Applying the Latest Evidence in Rural and Underserved Communities

Evolving Treatment Paradigms in Hepatocellular Carcinoma: Applying the Latest Evidence in Rural and Underserved Communities